---
title: "Cigna announces Q3 2026 dividend of R$ 0.227701746 per unit, payable Sept. 29"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300159458.md"
description: "Cigna announced a Q3 2026 dividend of R$ 0.2277 per unit, payable on September 29, 2026. Shares will trade ex-rights starting September 4, 2026, with the last day for rights being September 3."
datetime: "2026-09-25T19:25:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300159458.md)
  - [en](https://longbridge.com/en/news/300159458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300159458.md)
generator: "portal-rs"
---

# Cigna announces Q3 2026 dividend of R$ 0.227701746 per unit, payable Sept. 29

-   The CIGNA Group set a dividend of R$ 0.227701746 per unit for 3Q 2026. \* Shares trade ex-rights from Sept. 4, 2026; last day with rights is Sept. 3, 2026. \* Payment is scheduled for Sept. 29, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The CIGNA Corporation published the original content used to generate this news brief on September 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CI.US](https://longbridge.com/en/quote/CI.US.md)

## Related News & Research

- [Cigna Group $CI Stake Boosted by Envestnet Asset Management Inc.](https://longbridge.com/en/news/300107980.md)
- [Danica Pension Livsforsikringsaktieselskab Purchases New Shares in Cigna Group $CI](https://longbridge.com/en/news/296324360.md)
- [One4U cuts convertible bond conversion price to KRW 1,244 from KRW 1,776](https://longbridge.com/en/news/300258856.md)
- [Dongwha Enterprise guarantees KRW 150 billion SPC loan for Mpark funding###](https://longbridge.com/en/news/300266301.md)
- [Kodiak Sciences says Zenkuda meets primary endpoint in Phase 3 DAYBREAK wet AMD trial](https://longbridge.com/en/news/300289037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**